Page results
-
This patient information aims to address the questions you may have about surgical management of endometriosis.
-
This information will help you understand your forthcoming treatment and contains answers to many frequently asked questions.
-
Information about incentive spirometry (IS) for adults with sickle cell disorder.
-
The pelvic pain management service at UCLH was established in 2006 and our clinicians have a wealth of experience in managing women with abdominal and pelvic pain, and especially with those who have experienced complications following mesh implantation.
-
The Oesophageal and stomach surgery service works very closely with the specialist Upper Gastrointestinal (GI) service, gastroenterology, nutrition, oncology and radiology departments at UCLH. It comprises UCLH-based and Barts Health-based surgeons.
-
UCLH provides an audiological service for GPs who would like to refer patients for age related audiological assessments.
-
This information is for children and young people with type 1 diabetes using a hybrid closed loop (HCL).
-
We are making it easier and safer for patients to be seen in an Emergency Department (ED) or Accident and Emergency (A&E) department without waiting for long periods of time.
-
Information about community sickle cell and thalassaemia services provided via UCLH.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
File results
-
FOI/2022/0147 - Oesophageal and gastric cancer drug treatments
-
FOI/2022/0148 - Maternity related overseas services
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0151 - Omnipod patch pump
-
FOI/2022/0153 - Central water treatment equipment for renal dialysis
-
FOI/2022/0154 - Immunoglobulin treatments (for any disease)
-
FOI/2022/0155 - Patient hospital bedside and electronic patient notes
-
FOI/2022/0161 - Referral to treatment waiting times
-
FOI/2022/0167 - Prostate cancer drug treatments
-
FOI/2022/0168 - Geographic locations of patients